Search

Your search keyword '"Brun-Vezinet, F."' showing total 335 results

Search Constraints

Start Over You searched for: Author "Brun-Vezinet, F." Remove constraint Author: "Brun-Vezinet, F."
335 results on '"Brun-Vezinet, F."'

Search Results

1. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

2. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants

7. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

9. Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)

11. B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape

12. Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection

17. First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2)

25. Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection

26. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

27. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study

30. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type I variants

31. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants

32. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy

34. Isolation of a New Retrovirus in a Patient at Risk for Acquired Immunodeficiency Syndrome

35. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

36. Salivary Cytomegalovirus (CMV) Shedding, Glycoprotein B Genotype Distribution, and CMV Disease in Human Immunodeficiency Virus--Seropositive Patients

38. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants

39. Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing

40. An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study

41. European guidelines on the clinical management of HIV-1 tropism testing

42. Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

43. Update of the Drug Resistance Mutations in HIV-1: December 2010

44. Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing vs 1.0

46. Update of the drug resistance mutations in HIV-1: December 2009

47. Update of the Drug Resistance Mutations in HIV-1: December 2008

48. Update of the drug resistance mutations in HIV-1: Spring 2008

49. A natural CCL5/RANTES variant antagonist for CCR1 and CCR3

Catalog

Books, media, physical & digital resources